| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA125848
Max Phase: Preclinical
Molecular Formula: C15H22N2O5
Molecular Weight: 310.35
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(=O)N[C@H]1[C@H](OCc2ccccc2)O[C@H](CO)[C@@H](N)[C@@H]1O
Standard InChI: InChI=1S/C15H22N2O5/c1-9(19)17-13-14(20)12(16)11(7-18)22-15(13)21-8-10-5-3-2-4-6-10/h2-6,11-15,18,20H,7-8,16H2,1H3,(H,17,19)/t11-,12-,13-,14+,15-/m1/s1
Standard InChI Key: SDTSVIDVWTWQEF-ARILJUKYSA-N
Associated Targets(non-human)
Beta-1,4-galactosyltransferase 1 61 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 310.35 | Molecular Weight (Monoisotopic): 310.1529 | AlogP: -0.89 | #Rotatable Bonds: 5 |
| Polar Surface Area: 114.04 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.61 | CX Basic pKa: 8.41 | CX LogP: -0.96 | CX LogD: -2.01 |
| Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.56 | Np Likeness Score: 0.91 |
References
| 1. Field RA, Neville DC, Smith RW, Ferguson MA. (1994) Acceptor analogues as potential inhibitors of bovine -1,4-galactosyl transferase, 4 (3): [10.1016/0960-894X(94)80002-2] |
Source
Source(1):